Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

14.50
+1.6212.58%
Post-market: 14.800.3000+2.07%18:48 EDT
Volume:12.34M
Turnover:173.67M
Market Cap:1.43B
PE:-2.49
High:14.58
Open:13.22
Low:13.20
Close:12.88
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:2.62
T/O Rate:15.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.90
PE(LYR):-2.49

Loading ...

Ultragenyx Pharmaceutical Exec Says U.S. Per Patient Wholesale Acquisition Cost for Fayuvi is Set at $3.95 Million - Conf Call

THOMSON REUTERS
·
51 mins ago

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
2 hours ago

Ultragenyx Stock Jumps on Landmark FDA Approval

Dow Jones
·
2 hours ago

Ultragenyx Pharmaceutical Rises After FDA Approves Fayuvi for Sanfilippo Syndrome Type A

Dow Jones
·
2 hours ago

Ultragenyx Pharmaceutical - Fayuvi Expected to Ship to Qualified Treatment Centers Within 30-60 Days

THOMSON REUTERS
·
3 hours ago

Ultragenyx Sets $3.95 Million Price for Rare Disease Gene Therapy

Reuters
·
4 hours ago

US FDA Approves Ultragenyx's Gene Therapy for Rare Disorder

Reuters
·
4 hours ago

FDA: Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

THOMSON REUTERS
·
4 hours ago

Ultragenyx call volume above normal and directionally bullish

TIPRANKS
·
Yesterday

Ultragenyx treatment of GNE myopathy granted orphan designation

TIPRANKS
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Ultragenyx price target lowered to $32 from $43 at Barclays

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Nvidia, Tesla, Robinhood, Snowflake, Ultragenyx, Ciena, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 04

Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Sep 04

Ultragenyx falls -44.0%

TIPRANKS
·
Sep 04

Ultragenyx Pharmaceutical Down over 45%, on Pace for Record Low Close and Record Percent Decrease

Dow Jones
·
Sep 03

Ultragenyx Hits Record Low After Rare Disease Drug Trial Failure

Reuters
·
Sep 03

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03